The following table sets forth the computation of the Company’s basis in diluted net loss per share, as adjusted to give effect to the reverse stock split for the three months ended March 31, 2025 and 2024 (in thousands, except share and per share amounts):


	Three Months Ended March 31,
	2025			2024
Numerator:
Net loss	$	(10,860	)	$	(7,904	)
Denominator:
Weighted-average common shares outstanding		3,437,671			1,710,323
Weighted-average shares used in computing basic and diluted net loss per share		3,437,671			1,710,323
Net loss per share attributable to common stockholders—basic and diluted	$	(3.16	)	$	(4.62	)

As of March 31, 2025 and 2024, the Company’s potentially dilutive securities included unvested stock warrants and stock options, which have been excluded from the computation of diluted net loss per share attributable to common stockholders as the effect would be anti-dilutive. The issuance of pre-funded warrants and vested RSUs have been included in the computation of basic and diluted net loss per share attributable to common stockholders. Based on the amounts outstanding as of March 31, 2025 and 2024, the Company excluded the following potential common shares from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect, as adjusted to give effect to the reverse stock split:


	As of March 31,
	2025		2024
Options to purchase common stock		450,104		302,958
Common stock warrants		464		464
Total		450,568		303,422